Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suyu Shu

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Journal of Translational Medicine|November 30, 2004
Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cellsLi-Xin Wang, Wen-Xin Huang, Hallie Graor, et al.
Cancer Research|June 4, 2008
Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12Rongxiu Zheng, Peter A Cohen, Christopher A Paustian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumorsAnton V Gorbachev, Hirohito Kobayashi, Daisuke Kudo, et al.
Plos One|February 6, 2013
Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17Christopher Paustian, Patricia Taylor, Terrence Johnson, et al.
Cellular Immunology|January 9, 2007
Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccinationHideyuki Kuriyama, Satoshi Watanabe, Jorgen Kjaergaard, et al.
Blood|June 26, 2008
STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cellsPeter A Cohen, Gary K Koski, Brian J Czerniecki, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Journal of Translational Medicine|November 30, 2004
Adoptive immunotherapy of cancer with polyclonal, 108-fold hyperexpanded, CD4+ and CD8+ T cellsLi-Xin Wang, Wen-Xin Huang, Hallie Graor, et al.
Cancer Research|June 4, 2008
Paired Toll-like receptor agonists enhance vaccine therapy through induction of interleukin-12Rongxiu Zheng, Peter A Cohen, Christopher A Paustian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 6, 2007
CXC chemokine ligand 9/monokine induced by IFN-gamma production by tumor cells is critical for T cell-mediated suppression of cutaneous tumorsAnton V Gorbachev, Hirohito Kobayashi, Daisuke Kudo, et al.
Plos One|February 6, 2013
Extracellular ATP and Toll-like receptor 2 agonists trigger in human monocytes an activation program that favors T helper 17Christopher Paustian, Patricia Taylor, Terrence Johnson, et al.
Cellular Immunology|January 9, 2007
Mechanism of third signals provided by IL-12 and OX-40R ligation in eliciting therapeutic immunity following dendritic-tumor fusion vaccinationHideyuki Kuriyama, Satoshi Watanabe, Jorgen Kjaergaard, et al.
Blood|June 26, 2008
STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cellsPeter A Cohen, Gary K Koski, Brian J Czerniecki, et al.
Pageof 4